In this regard, GHSR agonist anamorelin was approved in 2020 in Japan for the treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer [248]
Quesenberry, P.J., Dooner, G.J., Del Tatto, M., Colvin, G.A., Johnson, K
We need better therapies to improve outcomes, but it is equally important to ensure responsible use of these medicationsnot for cosmetic makeovers, but for those who truly need them : , ,
Other symptoms may include: pain in the abdomen diarrhea fever nausea vomiting fatigue Colon cancer Though not as common, a person may experience excessive and odorous gas due to the presence of cancer of the colon
When these outcomes appear soon after starting a GLP-1 medication, they may point to a preventable adverse drug reaction rather than coincidence
Konkol, Samantha Wojnicki, Adrienne K